AZITROMICINA AUROBINDO 250mg tablets medication leaflet

J01FA10 azithromycin • Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins

Azithromycin is a macrolide antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is effective against a wide range of infections, including respiratory infections (bronchitis, pneumonia), skin and soft tissue infections, middle ear infections (otitis media), and sexually transmitted infections such as chlamydia.

Azithromycin works by inhibiting bacterial protein synthesis, blocking the growth and multiplication of bacteria. It is administered orally, usually once daily, for 3-5 days, depending on the type and severity of the infection.

Common side effects include nausea, diarrhea, abdominal pain, and skin rashes. In rare cases, severe adverse reactions such as allergic reactions, hepatotoxicity, or cardiac arrhythmias may occur. It is important for patients to follow the prescribed treatment regimen to prevent the development of bacterial resistance.

Azithromycin is a well-tolerated and effective antibiotic widely used for the treatment of common bacterial infections, contributing to improved patient health.

AZITROMICINA AUROBINDO 250mg tablets, azithromycin

General data about AZITROMICINA AUROBINDO 250mg

Substance: azithromycin

Date of last drug list: 01-06-2023

Commercial code: W63094004

Concentration: 250mg

Pharmaceutical form: tablets

Quantity: 6

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA

Holder: AUROBINDO PHARMA ROMANIA S.R.L. - ROMANIA

Number: 9358/2016/04

Shelf life: 2 years

Concentrations available for azithromycin

100mg/5ml, 125mg, 15mg/g, 200mg/5ml, 20mg/ml, 250mg, 2g, 40mg/ml, 500mg, 600mg